Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NiproTSE:8086 +0.39%70 Days Inventory is 206.18 as of Mar. 2026, which is 14% above its 10-year median of 181.37. GuruFocus rates TSE:8086 with a GF Score™ of 70/100 and a GF Value™ of 円1,457.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Nipro ranks worse than 60.53% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Nipro's Average Total Inventories for the
three
months ended in Mar. 2026 was 円262,668 Mil. Nipro's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円116,252 Mil.
Hence, Nipro's Days Inventory for the
three
months ended in Mar. 2026 was 206.18.
The historical rank and industry rank for Nipro's Days Inventory or its related term are showing as below:
TSE:8086'
s Days Inventory Range Over the Past 10 Years
Min: 162.67 Med: 181.37 Max: 207.85
Current: 207.36
During the past 13 years, Nipro's highest Days Inventory was 207.85. The lowest was 162.67. And the median was 181.37.
TSE:8086's Days Inventory is ranked worse than 60.53% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs TSE:8086: 207.36
Nipro's Days Inventory
increased
from Mar. 2025 (189.12) to Mar. 2026 (206.18).
It might indicate that Nipro's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nipro's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nipro's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.52.
Nipro (TSE:8086) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nipro's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nipro's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nipro Days Inventory Related Terms
Nipro Days Inventory Historical Data
* Premium members only.
The historical data trend for Nipro's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:8086 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Nipro's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nipro's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nipro (TSE:8086) has a Days Inventory of 206.18 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nipro and its competitors. This is 14% above median its historical median of 181.37. Over the past decade, Nipro's Days Inventory has ranged from 162.67 to 207.85. According to the industry distribution chart, Nipro ranks #477 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 60.5%.
Is Nipro's Days Inventory too high?
Nipro's current Days Inventory of 206.18 is 14% above median its 10-year median of 181.37. Over the past 10 years, this metric has ranged from a low of 162.67 to a high of 207.85. The Medical Devices & Instruments industry median Days Inventory is 179.12. Nipro's value of 206.18 is 15.1% above this industry median. Based on the distribution chart, Nipro ranks #477 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nipro has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #477 out of 788 companies for Days Inventory. This places Nipro in the lower half of its industry. The industry median Days Inventory is 179.12. Nipro's value of 206.18 is 15.1% above this benchmark. Historically, Nipro's own Days Inventory has ranged from 162.67 to 207.85 over the past decade. While the company's 10-year median is 181.37 vs. the industry median of 179.12, Nipro has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nipro's current Days Inventory of 206.18 is 15.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nipro and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current Days Inventory is 206.18, which is 14% above median its own 10-year median of 181.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Fairly Valued. The stock's GF Value™ is 円1,457.04, compared to a current price of 円1,552.50 — trading 6.6% above its estimated fair value. The current Days Inventory is 206.18, which is 14% above median its 10-year median of 181.37 and 15.1% above the Medical Devices & Instruments industry median of 179.12. Nipro's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nipro (TSE:8086), the current Days Inventory is 206.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (TSE:8086) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of 円1,552.50 is trading 6.6% above its estimated GF Value™ of 円1,457.04.
GuruFocus considers Nipro to be Fairly Valued.
Key valuation signals for TSE:8086:
Days Inventory: 206.18 (14% above median its 10-year median of 181.37)
GF Value™: 円1,457.04 vs. price of 円1,552.50 (6.6% above fair value)
Industry Position: 15.1% above the Medical Devices & Instruments median (#477 of 788)
No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
70GF Score
Get the complete analysis for TSE:8086
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8086 has been successfully added to your 
